Abstract

BackgroundParapneumonic empyema continues to be a disease of significant morbidity and mortality among children despite recent advances in medical management. To date, only a limited number of studies have assessed the burden of empyema in Asia.MethodsWe surveyed medical records of four representative large pediatric hospitals in China, Korea, Taiwan and Vietnam using ICD-10 diagnostic codes to identify children <16 years of age hospitalized with empyema or pleural effusion from 1995 to 2005. We also accessed microbiology records of cultured empyema and pleural effusion specimens to describe the trends in the epidemiology and microbiology of empyema.ResultsDuring the study period, we identified 1,379 children diagnosed with empyema or pleural effusion (China, n = 461; Korea, n = 134; Taiwan, n = 119; Vietnam, n = 665). Diagnoses of pleural effusion (n = 1,074) were 3.5 times more common than of empyema (n = 305), although the relative proportions of empyema and pleural effusion noted in hospital records varied widely between the four sites, most likely because of marked differences in coding practices. Although pleural effusions were reported more often than empyema, children with empyema were more likely to have a cultured pathogen. In addition, we found that median age and gender distribution of children with these conditions were similar across the four countries. Among 1,379 empyema and pleural effusion specimens, 401 (29%) were culture positive. Staphylococcus aureus (n = 126) was the most common organism isolated, followed by Streptococcus pneumoniae (n = 83), Pseudomonas aeruginosa (n = 37) and Klebsiella (n = 35) and Acinetobacter species (n = 34).ConclusionThe age and gender distribution of empyema and pleural effusion in children in these countries are similar to the US and Western Europe. S. pneumoniae was the second leading bacterial cause of empyema and pleural effusion among Asian children. The high proportion of culture-negative specimens among patients with pleural effusion or empyema suggests that culture may not be a sufficiently sensitive diagnostic method to determine etiology in the majority of cases. Future prospective studies in different countries would benefit from standardized case definitions and coding practices for empyema. In addition, more sensitive diagnostic methods would improve detection of pathogens and could result in better prevention, treatment and outcomes of this severe disease.

Highlights

  • Parapneumonic empyema continues to be a disease of significant morbidity and mortality among children despite recent advances in medical management

  • Hospitalizations for empyema and pleural effusion From the four study hospitals, this review identified a total of 1,379 patients diagnosed with empyema or pleural effusion (Table 1): 665 in Vietnam, 461 in China, 134 in Korea and 119 in Taiwan

  • Hospitalization data from Taiwan showed the lowest frequency of children with pleural effusion – only 4%, while 96% were coded as empyema

Read more

Summary

Introduction

Parapneumonic empyema continues to be a disease of significant morbidity and mortality among children despite recent advances in medical management. Children less than 5 years of age are at high risk for severe, life-threatening disease associated with bacterial and viral pathogens [3]. Several studies from developed countries suggest that the prevalence of empyema and pleural effusion may be increasing [6,7,8,9,10]. In these countries, pediatric empyema is often quickly identified and treated promptly with surgical intervention or pharmacologic therapy [11,12]. Severe pneumonia in children may be associated with necrotizing changes in a unilateral or bilateral pattern [15,16]. In China and Vietnam, the PCV7 has not been licensed (likely to occur in 2 years) and uptake of PPV has been slow and coverage is low (~1%)

Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.